Group One Trading’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-900
Closed -$92K 8831
2021
Q2
$92K Buy
+900
New +$90.4K ﹤0.01% 6055
2020
Q4
Sell
-500
Closed -$37K 7036
2020
Q3
$37K Sell
500
-100
-17% -$8.02K ﹤0.01% 4830
2020
Q2
$44K Hold
600
﹤0.01% 4447
2020
Q1
$35K Buy
+600
New +$41.7K ﹤0.01% 3942
2018
Q1
Sell
-5,000
Closed -$370K 5345
2017
Q4
$370K Buy
5,000
+2,200
+79% +$147K ﹤0.01% 2495
2017
Q3
$162K Buy
2,800
+100
+4% +$5.91K ﹤0.01% 2907
2017
Q2
$173K Buy
+2,700
New +$166K ﹤0.01% 2746
2013
Q4
Sell
-400
Closed -$17K 5562
2013
Q3
$17K Sell
400
-39,800
-99% -$1.6M ﹤0.01% 4263
2013
Q2
$1.46M Buy
+40,200
New +$1.22M 0.04% 592

Other funds holding USNA

Group One Trading's USNA Position: Q2 2021 in Review

Group One Trading sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 106 shares — an estimated $10.6K sold.

Group One Trading first reported a position in USNA in Q2 2013 and held it in 7 quarters. The position peaked at $260K in Q2 2013. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

  • Group One Trading reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
  • Group One Trading sold 106 Usana Health Sciences shares in Q2 2021, an estimated $10.6K.
  • Group One Trading first reported a position in Usana Health Sciences in Q2 2013 and held it in 7 quarters.
  • Group One Trading's Usana Health Sciences position peaked at $260K in Q2 2013.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.